NYSE · Technology
Hinge Health, Inc. (HNGE)
As-reported financials and recent SEC filings for Hinge Health, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$587.9M
Net income
$-528.3M
Net margin
-89.9%
Diluted EPS
$-7.77
ROE
-295.7%
P/E (TTM)
—
Market cap
$6.11B
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 |
|---|---|---|---|
| Revenue | $587.9M | $390.4M | $292.7M |
| Gross profit | $468.2M | $299.9M | $194.2M |
| Operating income | $-546.4M | $-31.9M | $-130.5M |
| Net income | $-528.3M | $-11.9M | $-108.1M |
| Diluted EPS | $-7.77 | $-0.22 | $-2.08 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-24
View on EDGAR →42026-06-24
View on EDGAR →42026-06-23
View on EDGAR →42026-06-18
View on EDGAR →1442026-06-16
View on EDGAR →1442026-06-16
View on EDGAR →1442026-06-16
View on EDGAR →1442026-06-16
View on EDGAR →Go deeper on HNGE
Search Hinge Health, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.